Skip to main content

Table 2 LABAs and LAMAs in development for combination therapies

From: Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease

Therapy

LABA/LAMA

Manufacturer

Dosage

Time to onset

Trough FEV1(difference from placebo)

Formoterol

LABA

Mercka

Twice daily

5 min [26]

50–90 mL [26]

4.5 μg (MDI) and 12 μg (DPI)

Indacaterol

LABA

Novartis

Once daily 150 and 300 μg (EU) (DPI) [20]

5 min [22]

130–180 mL (p < 0.001) [22]

Indacaterol

LABA

Novartis

Once daily 75 μg (US) (DPI) [21]

5 min [22]

≥120 mL (p < 0.001) [23, 33]

Olodaterol

LABA

Boehringer Ingelheim

Once daily 5 and 10 μg (Respimat®)

Not available

61–132 mL (p < 0.01) [24]

Vilanterol

LABA

GSK

Once daily 25 and 50 μg (DPI)

Median 6 min [25]

137–165 mL (p < 0.001) [25]

Aclidinium

LAMA

Almirall/Forest Laboratories

Twice daily 200–400 μg (DPI)

10–30 min [27, 28]

86–124 mL (p < 0.0001) [29]

Glycopyrronium

LAMA

Novartis

Once daily 50 μg (DPI)

5 min [19, 34]

91–108 mL (p < 0.001) [30, 34]

Glycopyrrolate

LAMA

Pearl Therapeutics

Twice daily 36 μg (MDI)

5 min [19]

Statistically superior to placebo (p < 0.0001) [31]

GSK233705

LAMA

GSK

Twice daily 200 μg

Not available

130 mL (p < 0.001) [32]

Tiotropium

LAMA

Boehringer Ingelheim

Once daily 18 μg (DPI) and 5 μg (via SMI)

15 min [18]

120–150 mL (p < 0.001) [18]

Umeclidinium (GSK573719)

LAMA

GSK

Once daily

Not available

Not available

  1. aOther companies are developing formoterol as part of a fixed-dose combination.
  2. PubMed and European Respiratory Society and American Thoracic Society congresses were searched for abstracts relating to LAMA/LABA therapies known to be in development as part of a combination. As trials were carried out in different patient populations and there were differences in background medications allowed/utilized, no direct comparisons can be made.
  3. DPI = dry powder inhaler; LABA = long-acting β2-agonist; LAMA = long-acting muscarinic antagonist; MDI = metered dose inhaler; SMI = Soft Mist™ Inhaler.